US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
ATE220327T1
(de)
*
|
1992-09-29 |
2002-07-15 |
Inhale Therapeutic Syst |
Pulmonale abgabe von aktiven fragmenten des parathormons
|
HUT75676A
(en)
*
|
1994-03-07 |
1997-05-28 |
Inhale Therapeutic Syst |
Methods and compositions for pulmonary delivery of insulin
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
DE69534318T2
(de)
*
|
1994-05-18 |
2006-04-20 |
Nektar Therapeutics, San Carlos |
Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6598603B1
(en)
*
|
1997-12-31 |
2003-07-29 |
Astra Aktiebolag |
Method for treating respiratory diseases
|
GB9827145D0
(en)
*
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6858199B1
(en)
*
|
2000-06-09 |
2005-02-22 |
Advanced Inhalation Research, Inc. |
High efficient delivery of a large therapeutic mass aerosol
|
EP2280021B1
(en)
*
|
1999-06-29 |
2016-02-17 |
MannKind Corporation |
Pharmaceutical formulations comprising insulin complexed with a diketopiperazine
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
ATE285821T1
(de)
|
1999-10-08 |
2005-01-15 |
Affinium Pharm Inc |
Fab i inhibitoren
|
IL149085A0
(en)
*
|
1999-10-29 |
2002-11-10 |
Inhale Therapeutic Syst |
A dry powder composition containing a di or tripeptide
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
CA2399464C
(en)
*
|
2000-02-11 |
2008-10-07 |
Medic-Aid Limited |
Drug delivery apparatus
|
PE20011227A1
(es)
*
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
AU6124601A
(en)
|
2000-05-10 |
2001-11-20 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7871598B1
(en)
*
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
EP2266549B1
(en)
*
|
2000-06-27 |
2019-08-07 |
Vectura Limited |
Method of making particles for use in a pharmaceutical composition
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
AU8111301A
(en)
|
2000-08-07 |
2002-02-18 |
Inhale Therapeutic Syst |
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
KR100743404B1
(ko)
|
2000-12-21 |
2007-07-30 |
넥타르 테라퓨틱스 |
폴리엔 항균제의 폐 전달
|
US7138419B2
(en)
*
|
2000-12-27 |
2006-11-21 |
Corus Pharma, Inc. |
Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate
|
ES2406405T3
(es)
*
|
2000-12-27 |
2013-06-06 |
Gilead Sciences, Inc. |
Aztreonam inhalable sin arginina para tratamiento y prevención de infecciones bacterianas pulmonares
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
US7214364B2
(en)
*
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
WO2003088897A2
(en)
*
|
2001-04-06 |
2003-10-30 |
Affinium Pharmaceuticals, Inc. |
Fab i inhibitors
|
CA2446904A1
(en)
*
|
2001-05-24 |
2003-04-03 |
Alexza Molecular Delivery Corporation |
Delivery of drug esters through an inhalation route
|
WO2002094229A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of muscle relaxants through an inhalation route
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
EG24184A
(en)
*
|
2001-06-15 |
2008-10-08 |
Otsuka Pharma Co Ltd |
Dry powder inhalation system for transpulmonary
|
CA2450678A1
(en)
*
|
2001-06-15 |
2002-12-27 |
Takeda Chemical Industries, Ltd. |
Novel polypeptide and use thereof
|
US20050013867A1
(en)
*
|
2001-10-19 |
2005-01-20 |
Lehrman S. Russ |
Use of proton sequestering agents in drug formulations
|
WO2003035028A1
(en)
*
|
2001-10-19 |
2003-05-01 |
Nektar Therapeutics |
Modulating charge density to produce improvements in the characteristics of spray-dried proteins
|
AUPR879601A0
(en)
*
|
2001-11-09 |
2001-12-06 |
Biota Scientific Management Pty Ltd |
Novel chemical compounds and their use
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
DE10206770A1
(de)
*
|
2002-02-19 |
2003-08-28 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung eines Pulverinhalativums enthaltend ein Salz des CGRP-Antagonisten BIBN4096
|
US6900317B2
(en)
*
|
2002-02-19 |
2005-05-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
|
US20040014679A1
(en)
*
|
2002-02-20 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
Inhalation powder containing the CGRP antagonist BIBN4096 and process for the preparation thereof
|
DE10207026A1
(de)
*
|
2002-02-20 |
2003-08-28 |
Boehringer Ingelheim Kg |
Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung
|
SI1494732T1
(sl)
*
|
2002-03-20 |
2008-08-31 |
Mannking Corp |
Inhalacijski aparat
|
JP2005520843A
(ja)
*
|
2002-03-20 |
2005-07-14 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
呼吸用持続性治療製剤
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
US7285269B2
(en)
*
|
2002-12-02 |
2007-10-23 |
Amgen Fremont, Inc. |
Antibodies directed to tumor necrosis factor
|
EP1575951B1
(en)
|
2002-12-06 |
2014-06-25 |
Debiopharm International SA |
Heterocyclic compounds, methods of making them and their use in therapy
|
AR042454A1
(es)
*
|
2002-12-13 |
2005-06-22 |
Otsuka Pharma Co Ltd |
Sistema de inhalacion de polvo para la administracion transpulmonar
|
JP2004238392A
(ja)
*
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
KR101173696B1
(ko)
*
|
2003-02-10 |
2012-08-13 |
바이엘 파마 악티엔게젤샤프트 |
플루오로퀴놀론의 국소 적용에 의한 호흡 기관의 세균성질환의 치료
|
EP1608377B1
(en)
|
2003-03-17 |
2008-10-01 |
Affinium Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
|
WO2004091487A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Wyeth |
Hemophilia treatment by inhalation of coagulation factors
|
WO2004096144A2
(en)
*
|
2003-04-28 |
2004-11-11 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
ATE510174T1
(de)
|
2003-05-21 |
2011-06-15 |
Alexza Pharmaceuticals Inc |
Schlag gezündete unabhängige heizeinheit
|
KR20120080243A
(ko)
*
|
2003-05-28 |
2012-07-16 |
노바르티스 아게 |
아미노산 및/또는 인지질로 부분 또는 완전 코팅된 수불용성 활성제 미립자의 제조를 위한 알코올성 수용액의 분무 건조법
|
MXPA06001674A
(es)
*
|
2003-08-12 |
2006-05-12 |
3M Innovative Properties Co |
Compuestos que contienen imidazo hidroxilamina-sustituidos.
|
DE10339197A1
(de)
*
|
2003-08-22 |
2005-03-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Sprühgetrocknete amorphe Pulver mit geringer Restfeuchte und guter Lagerstabilität
|
KR101106812B1
(ko)
*
|
2003-08-27 |
2012-01-19 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
|
EP1660026A4
(en)
*
|
2003-09-05 |
2008-07-16 |
3M Innovative Properties Co |
TREATMENT FOR CD5 + B CELL LYMPHOMA
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
WO2005025535A2
(en)
*
|
2003-09-15 |
2005-03-24 |
Vectura Limited |
Methods for preparing pharmaceutical compositions
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
US7544697B2
(en)
*
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
KR101154101B1
(ko)
*
|
2003-10-03 |
2012-06-11 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
알콕시 치환된 이미다조퀴놀린
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
JP2007511527A
(ja)
|
2003-11-14 |
2007-05-10 |
スリーエム イノベイティブ プロパティズ カンパニー |
オキシム置換イミダゾ環化合物
|
US8598192B2
(en)
*
|
2003-11-14 |
2013-12-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazoquinolines
|
MXPA06005910A
(es)
*
|
2003-11-25 |
2006-08-23 |
3M Innovative Properties Co |
Sistemas de anillo imidazo sustituido y metodos.
|
DE10358387A1
(de)
*
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
US20060182692A1
(en)
|
2003-12-16 |
2006-08-17 |
Fishburn C S |
Chemically modified small molecules
|
SI1694363T1
(sl)
*
|
2003-12-16 |
2014-03-31 |
Nektar Therapeutics |
Monodisperzni PEG-ilirani naloksolni sestavki
|
WO2005066170A1
(en)
*
|
2003-12-29 |
2005-07-21 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
AU2004312508A1
(en)
*
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
RU2388462C2
(ru)
|
2003-12-31 |
2010-05-10 |
Сайдекс, Инк. |
Ингаляционная композиция, содержащая сульфоалкиловый эфир циклодекстрина и кортикостероид
|
WO2005067898A2
(en)
|
2004-01-07 |
2005-07-28 |
Nektar Therapeutics |
Improved sustained release compositions for pulmonary administration of insulin
|
CA2552707C
(en)
*
|
2004-01-12 |
2018-03-27 |
Mannkind Corporation |
A method of reducing serum proinsulin levels in type 2 diabetics
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
EP1730751B1
(en)
*
|
2004-03-12 |
2009-10-21 |
The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin |
A magnetoresistive medium
|
PT2319500E
(pt)
*
|
2004-03-12 |
2013-01-23 |
Biodel Inc |
Composições de distribuição de fármacos de actuação rápida
|
AU2005228150A1
(en)
*
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
SE528121C2
(sv)
*
|
2004-03-29 |
2006-09-05 |
Mederio Ag |
Preparering av torrpulver för på förhand uppmätt DPI
|
JP2007534693A
(ja)
|
2004-04-23 |
2007-11-29 |
サイデックス・インコーポレイテッド |
スルホアルキルエーテルシクロデキストリンを含有するdpi製剤
|
US20060039985A1
(en)
*
|
2004-04-27 |
2006-02-23 |
Bennett David B |
Methotrexate compositions
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
EP1828167B1
(en)
*
|
2004-06-04 |
2014-08-06 |
Debiopharm International SA |
Acrylamide derivatives as antibiotic agents
|
US8017779B2
(en)
*
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
WO2006009826A1
(en)
*
|
2004-06-18 |
2006-01-26 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
US7897609B2
(en)
*
|
2004-06-18 |
2011-03-01 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
US7915281B2
(en)
*
|
2004-06-18 |
2011-03-29 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
|
US7872095B2
(en)
|
2004-07-19 |
2011-01-18 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
WO2006033713A2
(en)
*
|
2004-08-09 |
2006-03-30 |
Chiron Corporation |
Methods for ciprofloxacin inhalation
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
US7820676B2
(en)
|
2004-08-23 |
2010-10-26 |
Mannkind Corporation |
Diketopiperazine salts for drug delivery and related methods
|
WO2006025395A1
(ja)
*
|
2004-08-31 |
2006-03-09 |
Yasuhiko Shimizu |
キャリアフリーの細胞増殖因子を用いた慢性閉塞性肺疾患に対する医薬および処置システム
|
WO2006026760A2
(en)
*
|
2004-09-02 |
2006-03-09 |
3M Innovative Properties Company |
1-amino imidazo-containing compounds and methods
|
US8846607B2
(en)
*
|
2004-10-29 |
2014-09-30 |
President And Fellows Of Harvard College |
Particles for treatment of pulmonary infection
|
WO2006063072A2
(en)
*
|
2004-12-08 |
2006-06-15 |
3M Innovative Properties Company |
Immunomodulatory compositions, combinations and methods
|
US7943609B2
(en)
*
|
2004-12-30 |
2011-05-17 |
3M Innovative Proprerties Company |
Chiral fused [1,2]imidazo[4,5-C] ring compounds
|
WO2006083440A2
(en)
|
2004-12-30 |
2006-08-10 |
3M Innovative Properties Company |
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
|
CA2597092A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Coley Pharmaceutical Group, Inc. |
Aqueous gel formulations containing immune reponse modifiers
|
CA2597587A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
JP2008538550A
(ja)
|
2005-04-01 |
2008-10-30 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
|
AU2006232377A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
US7838532B2
(en)
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
CN101222927B
(zh)
|
2005-05-18 |
2016-08-24 |
拉普特制药有限公司 |
气溶胶化的氟喹诺酮类药物及其应用
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
CA2621806C
(en)
|
2005-09-14 |
2016-08-02 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
ITMI20051999A1
(it)
|
2005-10-21 |
2007-04-22 |
Eratech S R L |
Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
CA2632476A1
(en)
*
|
2005-12-05 |
2007-06-14 |
Affinium Pharmaceuticals, Inc. |
Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
|
EP2364735A3
(en)
|
2005-12-16 |
2012-04-11 |
Nektar Therapeutics |
Branched PEG conjugates of GLP-1
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
MX2008010222A
(es)
*
|
2006-02-10 |
2008-10-17 |
Pari Pharma Gmbh |
Antibioticos nebulizados para terapia de inhalacion.
|
WO2007095288A2
(en)
*
|
2006-02-13 |
2007-08-23 |
Nektar Therapeutics |
Methionine-containing protein or peptide compositions and methods of making and using
|
JP2009526860A
(ja)
*
|
2006-02-15 |
2009-07-23 |
ティカ レーケメデル アーベー |
安定したコルチコステロイド混合物
|
RU2403059C2
(ru)
|
2006-02-22 |
2010-11-10 |
Маннкайнд Корпорейшн |
Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
|
AU2007238114B2
(en)
*
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
ES2386972T3
(es)
*
|
2006-05-31 |
2012-09-10 |
Genzyme Corporation |
Uso de polisacáridos para la estimulación de la actividad enzimática
|
US7906506B2
(en)
*
|
2006-07-12 |
2011-03-15 |
3M Innovative Properties Company |
Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
|
US8318720B2
(en)
|
2006-07-20 |
2012-11-27 |
Affinium Pharmaceuticals, Inc. |
Acrylamide derivatives as Fab I inhibitors
|
FR2904532B1
(fr)
*
|
2006-08-03 |
2012-10-19 |
Soc Extraction Principes Actif |
Composition dermatologique et/ou cosmetique contenant des polypeptides ou des peptides
|
WO2008025560A1
(en)
*
|
2006-09-01 |
2008-03-06 |
Pari Pharma Gmbh |
Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
|
DK2066341T3
(en)
*
|
2006-09-01 |
2015-10-19 |
Csl Ltd |
PROCEDURE FOR INITIATING OR INDUCING AN IMMUNE RESPONSE
|
WO2008098374A1
(en)
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US8747872B2
(en)
*
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
JP5537425B2
(ja)
|
2007-06-26 |
2014-07-02 |
メルク・シャープ・アンド・ドーム・コーポレーション |
凍結乾燥抗真菌組成物
|
WO2009049159A1
(en)
|
2007-10-10 |
2009-04-16 |
Parion Sciences, Inc. |
Delivering osmolytes by nasal cannula
|
JP2011500514A
(ja)
*
|
2007-10-12 |
2011-01-06 |
シーエスエル、リミテッド |
汎発流行性インフルエンザウィルスに対する免疫応答を惹起する方法
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
WO2009120619A2
(en)
*
|
2008-03-24 |
2009-10-01 |
Novartis Ag |
Nuclease compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
WO2009143011A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Novartis Ag |
Antiviral compositions, methods of making and using such compositions, and systems for pulmonary delivery of such compositions
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
CA3086027C
(en)
|
2008-06-13 |
2022-05-17 |
Mannkind Corporation |
A dry powder inhaler and system for drug delivery
|
RU2470681C2
(ru)
|
2008-06-20 |
2012-12-27 |
Маннкайнд Корпорейшн |
Интерактивное устройство и способ профилирования усилий при ингаляции в реальном масштабе времени
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
EP2341942A1
(en)
*
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
EP2344200A2
(en)
*
|
2008-09-19 |
2011-07-20 |
Nektar Therapeutics |
Modified therapeutics peptides, methods of their preparation and use
|
US20100092526A1
(en)
*
|
2008-09-26 |
2010-04-15 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
PT2346509T
(pt)
|
2008-10-07 |
2020-08-05 |
Horizon Orphan Llc |
Inalação de levofloxacina para redução da inflamação pulmonar
|
WO2010042553A1
(en)
|
2008-10-07 |
2010-04-15 |
Mpex Pharmaceuticals, Inc. |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
WO2010057197A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
EP2676695A3
(en)
|
2009-03-11 |
2017-03-01 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
BRPI1011721B1
(pt)
|
2009-03-26 |
2021-11-16 |
Pulmatrix, Inc |
Formulações em pó seco inaláveis compreendendo sal de cátion de metal divalente e métodos para tratar doenças pulmonares
|
US9539233B2
(en)
*
|
2009-05-04 |
2017-01-10 |
Aridis Pharmaceuticals Inc. |
Gallium formulation for the treatment and prevention of infectious diseases
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
BRPI1011229B8
(pt)
|
2009-05-29 |
2021-05-25 |
Pearl Therapeutics Inc |
co-suspensão dispensável a partir de um inalador de dose medida compreendendo propelente, partículas de agente ativo e partículas em suspensão
|
WO2010142017A1
(en)
|
2009-06-09 |
2010-12-16 |
Defyrus, Inc . |
Administration of interferon for prophylaxis against or treatment of pathogenic infection
|
KR20210027546A
(ko)
|
2009-06-12 |
2021-03-10 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
RU2015130524A
(ru)
|
2009-09-04 |
2018-12-21 |
Раптор Фармасьютикалз Инк. |
Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
US9072783B2
(en)
|
2009-11-18 |
2015-07-07 |
Aridis Pharmaceuticals |
Highly dispersible powders, compositions and methods for preparation
|
US20110233469A1
(en)
*
|
2009-12-21 |
2011-09-29 |
Brent Petersen |
Leucine/Peptide Composition and Method of Formulation
|
WO2011131720A1
(en)
*
|
2010-04-20 |
2011-10-27 |
Octapharma Ag |
New stabilizing agent for pharmaceutical proteins
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
EP2448571B1
(en)
|
2010-08-30 |
2013-06-12 |
Pulmatrix, Inc. |
Respirably dry powder comprising calcium lactate, sodium chloride and leucine
|
CA2809666C
(en)
|
2010-08-30 |
2020-09-22 |
Michael M. Lipp |
Dry powder formulations and methods for treating pulmonary diseases
|
KR20180122475A
(ko)
|
2010-09-29 |
2018-11-12 |
풀매트릭스 오퍼레이팅 컴퍼니, 인크 |
흡입용의 1가 금속 양이온 건조 분말
|
ES2899621T3
(es)
|
2010-09-29 |
2022-03-14 |
Pulmatrix Operating Co Inc |
Polvos secos catiónicos que comprenden sal de magnesio
|
US9045728B2
(en)
|
2010-12-02 |
2015-06-02 |
Oncolytics Biotech Inc. |
Liquid viral formulations
|
EP2646052B1
(en)
|
2010-12-02 |
2017-03-29 |
Oncolytics Biotech Inc. |
Lyophilized viral formulations
|
CA2823628A1
(en)
|
2011-01-05 |
2012-07-12 |
Hospira, Inc. |
Spray drying vancomycin
|
LT2670242T
(lt)
|
2011-01-31 |
2022-06-27 |
Avalyn Pharma Inc. |
Aerozoliniai pirfenidono ir piridono anologų junginiai, ir jų panaudojimas
|
US10358043B2
(en)
*
|
2011-03-31 |
2019-07-23 |
Elite Power Solutions, LLC |
Golf cart battery system
|
EP2694402B1
(en)
|
2011-04-01 |
2017-03-22 |
MannKind Corporation |
Blister package for pharmaceutical cartridges
|
CA2836643C
(en)
*
|
2011-05-19 |
2017-11-14 |
Savara, Inc. |
Dry powder vancomycin compositions and associated methods
|
US9572774B2
(en)
|
2011-05-19 |
2017-02-21 |
Savara Inc. |
Dry powder vancomycin compositions and associated methods
|
CN103561757B
(zh)
*
|
2011-06-07 |
2016-01-06 |
旭化成制药株式会社 |
高纯度含pth冷冻干燥制剂及其制造方法
|
US8945605B2
(en)
|
2011-06-07 |
2015-02-03 |
Parion Sciences, Inc. |
Aerosol delivery systems, compositions and methods
|
EP2717855A4
(en)
|
2011-06-07 |
2014-11-12 |
Parion Sciences Inc |
PROCESSING METHODS
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
CN103945859A
(zh)
|
2011-10-24 |
2014-07-23 |
曼金德公司 |
用于治疗疼痛的方法和组合物
|
EP2790761B1
(en)
|
2011-12-16 |
2022-05-11 |
Novartis AG |
Passive powder aerosolization apparatus
|
KR101342485B1
(ko)
*
|
2012-02-29 |
2013-12-17 |
미원상사주식회사 |
트리펩타이드 및 이를 함유하는 노화방지, 주름개선, 미백 및 항염효능의 화장료 조성물
|
NZ629722A
(en)
|
2012-02-29 |
2017-03-31 |
Pulmatrix Operating Co Inc |
Inhalable dry powders
|
WO2013176622A1
(en)
*
|
2012-05-21 |
2013-11-28 |
Agency For Science, Technology And Research (A*Star) |
A dry powder formulation
|
EA032734B1
(ru)
|
2012-05-29 |
2019-07-31 |
Парион Сайэнс, Инк. |
Дендримероподобные аминоамиды, обладающие активностью блокаторов натриевых каналов, для лечения сухости глаз и других заболеваний слизистых оболочек
|
HUE043836T2
(hu)
|
2012-06-19 |
2019-09-30 |
Debiopharm Int Sa |
(E)-N-metil-N-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamid prodrug származékai
|
CN104619369B
(zh)
|
2012-07-12 |
2018-01-30 |
曼金德公司 |
干粉药物输送系统和方法
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
RU2671976C2
(ru)
|
2012-12-17 |
2018-11-08 |
Пэрион Сайенсиз, Инк. |
Соединения 3,5-диамино-6-хлор-n-(n-(4-фенилбутил)карбамимидоил)пиразин-2-карбоксамида
|
PL2931713T3
(pl)
|
2012-12-17 |
2017-06-30 |
Parion Sciences, Inc. |
Chloro-pirazynowe pochodne karboksyamidowe do leczenia chorób, którym sprzyja niedostateczne nawilżenie błon śluzowych
|
CA2896686A1
(en)
|
2012-12-17 |
2014-06-26 |
Parion Sciences, Inc. |
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
JP6523247B2
(ja)
|
2013-03-15 |
2019-05-29 |
マンカインド コーポレイション |
微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
|
BR112015022784B1
(pt)
|
2013-03-15 |
2023-02-14 |
Pearl Therapeutics, Inc |
Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
|
RU2015146871A
(ru)
|
2013-04-01 |
2017-05-10 |
Пулматрикс, Инк. |
Сухие порошки с тиотропием
|
JP2016519160A
(ja)
|
2013-05-22 |
2016-06-30 |
パール セラピューティクス,インコーポレイテッド |
3つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム
|
KR102321339B1
(ko)
*
|
2013-07-18 |
2021-11-02 |
맨카인드 코포레이션 |
열-안정성 건조 분말 약제학적 조성물 및 방법
|
WO2015017728A1
(en)
|
2013-07-31 |
2015-02-05 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP3091976A4
(en)
|
2014-01-10 |
2017-10-11 |
Genoa Pharmaceuticals Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
JP7158853B2
(ja)
|
2014-10-10 |
2022-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
対象における食物アレルギーまたは呼吸器アレルギーを処置するための、かつ上記対象の鼻腔内に投与するための免疫原性組成物
|
MY189221A
(en)
|
2016-02-26 |
2022-01-31 |
Debiopharm Int Sa |
Medicament for treatment of diabetic foot infections
|
RU2021132299A
(ru)
*
|
2016-06-30 |
2021-12-10 |
Филип Моррис Продактс С.А. |
Никотиносодержащие частицы и композиции
|
WO2018075954A2
(en)
|
2016-10-21 |
2018-04-26 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
JP2020503843A
(ja)
|
2016-10-21 |
2020-02-06 |
アディマブ, エルエルシー |
抗呼吸器合胞体ウイルス抗体、及び、それらの生成及び使用の方法
|
CN110035771B
(zh)
|
2016-10-21 |
2024-03-08 |
阿迪马布有限责任公司 |
抗呼吸道合胞病毒抗体及其产生和使用方法
|
CN106727348B
(zh)
*
|
2016-12-20 |
2020-10-13 |
广州中大南沙科技创新产业园有限公司 |
防潮抗湿的低密度载体颗粒及其制备方法和应用
|
EP3559016A1
(en)
*
|
2016-12-23 |
2019-10-30 |
University of Copenhagen |
A co-amorphous form of a substance and a dipeptide
|
US20220401365A1
(en)
*
|
2019-10-28 |
2022-12-22 |
Astrazeneca Ab |
Dry powder formulations containing leucine and trileucine
|
CN114867748A
(zh)
|
2019-10-28 |
2022-08-05 |
免疫医疗有限公司 |
结合胸腺基质淋巴细胞生成素(tslp)的抗体的干粉制剂及其使用方法
|
TW202241410A
(zh)
*
|
2021-01-08 |
2022-11-01 |
大陸商江蘇恒瑞醫藥股份有限公司 |
可經由定量吸入器遞送的藥物組合物
|
WO2023283439A1
(en)
|
2021-07-09 |
2023-01-12 |
Astrazeneca Pharmaceuticals Lp |
Compositions, methods and systems for aerosol drug delivery
|
US20230053812A1
(en)
*
|
2021-07-27 |
2023-02-23 |
Aurobindo Pharma Ltd |
Stable peptide formulations for oral use
|
WO2023091081A2
(en)
*
|
2021-11-16 |
2023-05-25 |
Agency For Science, Technology And Research |
Inhalable recombinant protein powder formulation for treating genetic and autoimmune disorders
|
WO2023119093A1
(en)
|
2021-12-20 |
2023-06-29 |
Astrazeneca Ab |
Compositions, methods and systems for aerosol drug delivery
|
WO2023212191A1
(en)
|
2022-04-28 |
2023-11-02 |
Astrazeneca Ab |
Combination of albuterol and budesonide for the treatment of asthma
|
WO2023229023A1
(ja)
*
|
2022-05-25 |
2023-11-30 |
学校法人 名城大学 |
粉末剤及びその製造方法
|